Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for tyrosine in Related Substance Name (approximate match)

Showing 351 - 360 of 381 results

First page
Previous page
36
Next page
Next page

LAPULEUCEL-T

J5Z87L8ROA

Status:

Investigational

Source:

NCT01353222: Phase 2 Interventional Terminated Urothelial Carcinoma

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01353222

Class:

STRUCTURALLY DIVERSE

ETBX-021

S4MK9TOL0D

Status:

Investigational

Source:

NCT03563144: Phase 2 Interventional Withdrawn Metastatic Pancreatic Cancer

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03563144

Class:

STRUCTURALLY DIVERSE

COCOA

D9108TZ9KG

Status:

US Approved Allergenic Extract (1972)

Source:

BLA102192

(1972)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42a03973-e3db-49f2-9264-f76aa831c045

First marketed in 1921

Source:

Oil of Theobroma U.S.P.

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

Class:

STRUCTURALLY DIVERSE

CDX-3379

00X6I56YXR

Status:

Investigational

Source:

NCT02473731: Phase 1 Interventional Completed Squamous Cell Carcinoma of the Head and Neck

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02473731

Class:

CONCEPT

AV-203

841P9W25WA

Status:

Investigational

Source:

NCT01603979: Phase 1 Interventional Completed Solid Tumors

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01603979

Class:

CONCEPT

REGN-1400

93F274N35Z

Status:

Investigational

Source:

NCT01727869: Phase 1 Interventional Completed Cancer

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01727869

Class:

CONCEPT

FS-102

Z27ZI1MZY9

Status:

Investigational

Source:

NCT02286219: Phase 1 Interventional Completed Solid Tumors That Overexpress HER2 (HER2 Positive)

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02286219

Class:

CONCEPT

DHES-0815A

1E55T9OY5I

Status:

Investigational

Source:

NCT03451162: Phase 1 Interventional Completed Breast Cancer

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03451162

Class:

CONCEPT

GBR-1302

HA8VPA83AE

Status:

Investigational

Source:

NCT03983395: Phase 1/Phase 2 Interventional Terminated Breast Cancer

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03983395

Class:

CONCEPT

AGS62P1

37I4D4Q7S2

Status:

Investigational

Source:

NCT02864290: Phase 1 Interventional Terminated Acute Myeloid Leukemia

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02864290

Class:

CONCEPT

Structurally Diverse

LAPULEUCEL-T

Structurally Diverse

ETBX-021

Structurally Diverse

COCOA

Concept

CDX-3379

Concept

AV-203

Concept

REGN-1400

Concept

FS-102

Concept

DHES-0815A

Concept

GBR-1302

Concept

AGS62P1

Showing 351 - 360 of 381 results

First page
Previous page
36
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1